Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis

PURPOSE: The Oncotype DX© 21-gene Recurrence Score (RS) estimates the risk of distant disease recurrence in early-stage estrogen receptor-positive, human epidermal growth factor receptor-2-negative (ER+/HER2− ) breast cancer. Using RS to estimate risk of locoregional recurrence (LRR) is less conclus...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Matthew G., Cleere, Eoin F., O’Donnell, John P., Gaisor, Sara, Lowery, Aoife J., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114034/
https://www.ncbi.nlm.nih.gov/pubmed/35426541
http://dx.doi.org/10.1007/s10549-022-06580-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114034/
https://www.ncbi.nlm.nih.gov/pubmed/35426541
http://dx.doi.org/10.1007/s10549-022-06580-w

Ejemplares similares